De novo membranoproliferative glomerulonephritis III in a renal transplant patient: case report and review of the literature

Transpl Int. 2012 May;25(5):e58-61. doi: 10.1111/j.1432-2277.2012.01452.x. Epub 2012 Mar 1.

Abstract

Idiopathic membranoproliferative glomerulonephritis (MPGN) is a rare cause of renal failure with a cumulative incidence of 0.3% of all ESRD and 4% of all primary glomerulonephritis for types I and II. Membranoproliferative glomerulonephritis type III is more uncommon and idiopathic de novo MPGN III in a renal transplant patient has not been reported. We present the case of a 57-year old white female patient with a diagnosis of lithium toxicity as cause of end stage renal disease (ESRD) who developed MPGN III in her allograft 6 years after a renal transplant. Despite treatment, she progressed to ESRD within four and a half years from the time of diagnosis.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Antimanic Agents / toxicity
  • Bipolar Disorder / drug therapy
  • Female
  • Glomerulonephritis, Membranoproliferative / drug therapy
  • Glomerulonephritis, Membranoproliferative / etiology*
  • Glomerulonephritis, Membranoproliferative / pathology
  • Humans
  • Kidney Failure, Chronic / chemically induced
  • Kidney Failure, Chronic / surgery
  • Kidney Transplantation / adverse effects*
  • Kidney Transplantation / pathology
  • Lithium / toxicity
  • Middle Aged
  • Time Factors

Substances

  • Antimanic Agents
  • Lithium